Endo Health buys migraine patch-maker for $105M

12/17/2013 | Reuters

Endo Health Solutions agreed to pay about $105 million to acquire NuPathe and its lead product Zecuity, the only FDA-approved prescription patch for migraine. The acquisition could be finalized early next year, and Endo plans to commercialize the migraine patch in the first half of 2014.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC
Senior Counsel Commercial
RAI Services Company
Winston Salem, NC
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL